Skip to content

Mechanisms of Muscle Blood Flow Dysregulation and Exercise Intolerance in Chronic Kidney Disease

Mechanisms of Muscle Blood Flow Dysregulation and Exercise Intolerance in Chronic Kidney Disease

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02664519
Enrollment
32
Registered
2016-01-27
Start date
2016-01-31
Completion date
2021-03-18
Last updated
2021-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

Chronic Kidney Disease, Functional sympatholysis, Exercise training, Exercise intolerance, Handgrip exercise, Near infrared spectroscopy, Lower body negative pressure

Brief summary

Patients with chronic kidney disease (CKD) experience fatigue and exercise intolerance. Increased oxidative stress in CKD may be a contributing factor. The role of impaired muscle blood flow regulation has not been fully explored. The investigators hypothesize that functional sympatholysis is exaggerated in CKD and this is associated with increased oxidative stress. The investigators also hypothesize that exercise training will improve functional sympatholysis and oxidative stress

Detailed description

Progressive muscle weakness and premature fatigue are characterize the condition of chronic kidney disease (CKD) which can be very debilitating. Mechanisms underlying exercise intolerance in CKD is not completely understood. Previous studies have demonstrated impaired skeletal muscle vasodilation during exercise in CKD patients, which may contribute to exercise intolerance. Normally, there is blunting of sympathetic mediated vasoconstriction in exercising muscle to allow for steady blood supply to exercising muscles. This phenomenon is called functional sympatholysis. Functional sympatholysis is impaired by increases in reactive oxygen specie and may be impaired in CKD. Experiments will be performed on 2 groups of subjects 1) Normal kidney function (eGFR\>90) 2) Stage 2-3 CKD (eGFR 30-89). VAsoactive medications will be held for 72 hours before study. All participants will attend a baseline study visit, which will include a physical examination, a medical history review, vital sign measurements, and blood collection. Muscle nerve activity and muscle oxygenation will be measured while the subjects perform hand grip exercise at 30% maximum voluntary contraction with and without lower body negative pressure (- 20 mmHg). Muscle blood flow will be measured before and after hand grip exercises. CKD subjects will then be randomized to exercise training (to squeeze a tennis ball repeatedly for at least 30 min/day) or no exercise training for 28 days. Procedures in baseline visit will be repeated followed by cross over to alternate group for 28 days followed by repeat of baseline procedures. Blood flow, muscle oxygenation and muscle nerve activity will be compared between CKD and normal subjects as well as before and after exercise training for CKD subjects.

Interventions

BEHAVIORALForearm exercise training

Subjects will be asked to squeeze a tennis ball repeatedly for at least 30 min/day for 28 days at an approximate rate of 20 squeezes/min.

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Normotensive adults * CKD 2-3

Exclusion criteria

* Blood Pressure ≥140/90 * eGFR \>60ml/min/1.73 m2 or eGFR \<30ml/min/1.73 m2 * Any evidence of cardiopulmonary disease, left ventricular hypertrophy or systolic dysfunction by echocardiography. * Diabetes mellitus or other systemic illness * Pregnancy * Any history of substance abuse or current cigarette use * Any history of psychiatric illness * History of malignancy

Design outcomes

Primary

MeasureTime frameDescription
Change in muscle oxygenationAfter 28 daysTissue oxygenation will be recorded using Near-infrared spectroscopy (NIRS)

Secondary

MeasureTime frameDescription
Change in Forearm vascular conductance (FVC)After 28 daysDoppler ultrasonography to measure blood flow
Change in plasma isoprostanesAfter 28 daysPlasma isoprostanes will be used as a measure of oxidative stress
Change in muscle sympathetic nerve activity (MSNA)After 28 daysMSNA will be measured using tiny tungsten wire inserted into the common peroneal nerve below fibular head.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026